A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants

Reproductive Health

Volumn 4, Issue , 2007, Pages

  Monteiro Dantas, Cecilia ^a   Espejo Arce, Ximena ^a   Lui Filho, Jeffrey F ^a   Fernandes, Arlete M ^a   Monteiro, Ilza ^a   Bahamondes, Luis ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ETONOGESTREL; LEVONORGESTREL;

ADULT; ARTICLE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG IMPLANT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FOREARM; HORMONAL CONTRACEPTION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; RADIUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 38349070947     PISSN: None     EISSN: 17424755     Source Type: Journal    
DOI: 10.1186/1742-4755-4-11     Document Type: Article

References (33)

1. Progestogen-only contraception and bone mineral density: a systematic review. KM Curtis SL Martins, Contraception 2006 73 470 487 10.1016/j. contraception.2005.12.010 16627031
2. Involutional osteoporosis. BL Riggs LJ Melton, N Engl J Med 1986 314 1676 1686 3520321
3. Bone gain in young adult women. RR Recker KM Davies SM Hinders RP Heaney MR Stegman DB Kimmel, JAMA 1992 268 2403 2408 10.1001/jama.268.17.2403 1404797
4. Bone density in long-term users of depot medroxyprogesterone acetate. B Gbolade S Ellis B Murby S Randall R Kirkman, Br J Obstet Gynaecol 1998 105 790 794 9692421
5. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera. L Bahamondes M Trevisan L Andrade NM Marchi S Castro A Faundes, Contraception 2000 62 23 27 10.1016/S0010-7824(00) 00132-3 11024225
6. Bone density in women receiving depot medroxyprogesterone acetate for contraception. T Cundy M Evans H Roberts D Wattie R Ames IR Reid, BMJ 1991 303 13 16 1830502
7. Long-term depot-medroxyprogesterone acetate and bone mineral density. OS Tang G Tang P Yip B Li S Fan, Contraception 1999 59 25 29 10.1016/S0010-7824(98) 00144-9 10342083
8. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. DB Petitti G Piaggio S Mehta MC Cravioto O Meirik, Obstet Gynecol 2000 95 736 744 10.1016/S0029-7844(00)00782-1 10775740
9. Talk Paper Black Box Warning Added Concerning Long-Term Use of Depo-Provera Contraceptive Injection. United States Food and Drug Administration, November 17, 2004
10. Updated prescribing advice on the effect of Depo-Provera contraception on bones HSS. G Duff, http://www.mhra.gov.uk/home/idcplg?IdcService= GET_FILE&dDocName=con019478&RevisionSelectionMethod=Latest (MD) 39-2004, November, 19, 2004
11. WHO statement on hormonal contraception and bone health. C D'Arcangues, Contraception 2006 73 443 444 10.1016/j.contraception.2006.01.002 16627029
12. Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women. S Taneepanichskul S Intaraprasert U Theppisai K Chaturachinda, Contraception 1997 56 153 155 10.1016/S0010-7824(97)00116-9 9347205
13. Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism. X Di Y Li C Zhang J Jiang S Gu, Contraception 1999 60 161 166 10.1016/S0010-7824(99)00080-3 10640160
14. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. R Beerthuizen A van Beek R Massai L Makarainen J Hout HC Bennink, Hum Reprod 2000 15 118 122 10.1093/humrep/15.1.118 10611199
15. A prospective study of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants. L Bahamondes C Monteiro-Dantas X Espejo-Arce AM Dos Santos Fernandes JF Lui-Filho M Perrotti CA Petta, Hum Reprod 2006 21 466 470 10.1093/humrep/dei358 16253974
16. Clinical Trials: A Practical Approach. SJ Pocock, Chichester: John Wiley and Sons 1987
17. Smoking and fracture risk: a meta-analysis. JA Kanis O Johnell A Oden H Johansson C De Laet JA Eisman S Fujiwara H Kroger EV McCloskey D Mellstrom LJ Melton H Pols J Reeve A Silman A Tenenhouse, Osteoporos Int 2005 16 155 62 10.1007/s00198-004-1640-3 15175845
18. Alcohol intake as a risk factor for fracture. JA Kanis H Johansson O Johnell A Oden C De Laet JA Eisman H Pols A Tenenhouse, Osteoporos Int 2005 16 737 742 10.1007/s00198-004-1734-y 15455194
19. Statistical Methods in Medical Research. P Armitage, New York: A Halsted Press Book, John Wiley and Sons 1991
20. Assessment of Fracture Risk and its Application to Screening for Post-menopausal Osteoporosis: Report of a WHO Study Group. World Health Organization, WHO, Geneva (WHO technical report series 843) 1994
21. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. HB Croxatto J Urbancsek R Massai H Coelingh Bennink A van Beek, Hum Reprod 1999 14 976 981 10.1093/humrep/14.4.976 10221230
22. The pharmacodynamics and efficacy of Implanon. An overview of the data. HB Croxatto L Makarainen, Contraception 1998 58 Suppl 91 97 10.1016/S0010- 7824(98)00118-8
23. Estradiol plasma levels during long-term treatment with Norplant subdermal implants. HB Croxatto S Diaz M Pavez A Brandeis, Contraception 1988 38 465 475 10.1016/0010-7824(88)90087-X 3145171
24. Progestin implants. HB Croxatto, Steroids 2000 65 681 685 10.1016/S0039-128X(00)00124-0 11108876
25. Norplant implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning. S Diaz MV Reyes A Zepeda GB Gonzalez JM Lopez C Campino HB Croxatto, Hum Reprod 1999 14 2499 2505 10.1093/humrep/14.10.2499 10527977
26. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women. T Naessen SE Olsson J Gudmundson, Contraception 1995 52 35 39 10.1016/0010-7824(95)00121-P 8521712
27. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo Provera), levonorgestrel (Norplant), or oral contraceptives. BA Cromer JM Blair JD Mahan L Zibners Z Naumovski, J Pediatr 1996 129 671 676 10.1016/S0022-3476(96)70148-8 8917232
28. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. D Marshall O Johnell H Wedel, BMJ 1996 312 1254 1259 8634613
29. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. ES Siris PD Miller E Barrett-Connor KG Faulkner LE Wehren TA Abbott ML Berger AC Santora LM Sherwood, JAMA 2001 286 2815 2822 10.1001/jama.286.22. 2815 11735756
30. Steroidal contraceptives: effect on bone fractures in women. LM Lopez DA Grimes KF Schulz KM Curtis, Cochrane Database Syst Rev 2006 4 CD006033 17054270
31. Clinical use of bone densitometry: scientific review. SR Cummings D Bates DM Black, JAMA 2002 288 1889 97 10.1001/jama.288.15.1889 12377088
32. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women. BJ Orr-Walker MC Evans RW Ames JM Clearwater T Cundy IR Reid, Clin Endocrinol (Oxf) 1998 49 615 618 10.1046/j.1365-2265.1998.00582.x 10197077
33. Is bone mineral density predictive of fracture risk reduction? CA Cefalu, Curr Med Res Opin 2004 20 341 349 10.1185/030079903125003062 15025843